Generics Bulletin Podcasts

The Generics Bulletin Podcast takes you inside the trends and decisions driving the global generics and biosimilars industry. Created for industry professionals, episodes published bi-monthly feature specialist reporters and expert voices unpacking regulatory shifts, pricing pressures, market access and competitive dynamics – alongside on-the-ground insights from key industry conferences. Visit us at https://insights.citeline.com/generics-bulletin to sign up for newsletters and stay ahead. For any podcast feedback or queries, you can now reach us at podcasts@norstella.com .

Generics Bulletin Podcasts is a business podcast hosted by Unknown Host, with 0 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Unknown Host hosts Generics Bulletin Podcasts, a business show with 0 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Generics Bulletin Podcasts

  Off-Patent, On Record: A Story Of Patients Fighting For Accessible Cystic Fibrosis Treatment

  Sep 2, 202622 minS0

  <p>In the second episode of Off-Patent, On Record, Generics Bulletin’s senior reporter Urtė Fultinavičiūtė hears how patients with cystic fibrosis travelled to Bangladesh to collect generic version of Vertex’s highly inaccessible Trikafta. Urtė is joined by Wilna Lottering and her son Josh from South Africa, as well as Gayle Pledger, a cystic fibrosis campaigner. </p>

  ListenShow Notes
• 

  Generics Bulletin Podcasts

  Generic Bulletin Trailer

  Aug 19, 20261 minS0

  ListenShow Notes
• 

  Generics Bulletin Podcasts

  Off-Patent, On Record: View Through The Journalist's Lens With Generics Bulletin's Dave Wallace

  Aug 4, 202624 minS0

  <p>Generics Bulletin’s senior reporter Urtė Fultinavičiūtė launches a new interview podcast series “Off-Patent, On Record.” In the inaugural episode, Urtė is joined by Dave Wallace, executive editor at Generics Bulletin, who has been covering the off-patent drug industry as a journalist and editor for 16 years.</p>

  ListenShow Notes
• 

  Generics Bulletin Podcasts

  The Next Era Of Oncology Biosimilars

  Jul 22, 202617 minS0

  Oncology biosimilars have already helped expand access to established biologic treatments while supporting more sustainable healthcare spending. As the market moves towards increasingly complex therapies, however, identifying viable opportunities will require more than monitoring patent expiries. In this podcast, ICON experts Colin Farquharson and Martin Lachs, discuss how scientific innovation, evolving standards of care and changing market dynamics are influencing the next generation of oncology biosimilars. This podcast explores: How oncology biosimilars are moving from proof of concept towards broader adoption The potential opportunities and challenges associated with antibody-drug conjugates and bispecific antibodies Why patent expiry alone is not enough...

  ListenShow Notes
• 

  Generics Bulletin Podcasts

  The Generics Bulletin Podcast: Summer Conferences

  Jul 20, 202622 minS0

  <p>Generics Bulletin's editorial team discusses the recent Medicines for Europe legal and annual conferences, attended by executive editor Dave Wallace, as well as the Medicines UK conference attended by reporter Anabel Costa-Ferreira.</p>

  ListenShow Notes

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.